• Home
  • Store
    • Newsletter Subscriptions
    • Multimedia
    • Books
    • eBooks
    • ABPN SA Courses
    • Social Work Courses
  • CME Center
  • Multimedia
    • Podcast
    • Webinars
    • Blog
    • Psychiatry News Videos
    • Medication Guide Videos
  • Newsletters
    • General Psychiatry
    • Child Psychiatry
    • Addiction Treatment
    • Hospital Psychiatry
    • Geriatric Psychiatry
    • Psychotherapy and Social Work
  • FAQs
  • Med Fact Book Apps
  • Log In
  • Register
  • Welcome
  • Sign Out
  • Subscribe
Home » Topics » Hospital Psychiatry

Hospital Psychiatry
Hospital Psychiatry RSS Feed RSS

Clinical Update

Clozapine: Monitoring With Skill

April 1, 2024
Nicole Turnier, MD.
From The Carlat Hospital Psychiatry Report
Issue Links: Editorial Information | PDF of Issue

Nicole Turnier, MD. Psychiatrist, Rochester Center for Behavioral Medicine, Rochester Hills, MI. 

Dr. Turnier has no financial relationships with companies related to this material.

Few medications are as complex to use as clozapine. This guide will equip you with the necessary knowledge and insights to prescribe it, monitor for side effects, and recognize key risks.


Read More
standing on bridge shutterstock_124603273.jpg
Expert Q&A

Unraveling the Paradox of Nonsuicidal Self-Injury

April 1, 2024
Katherine L. Dixon-Gordon, PhD
From The Carlat Hospital Psychiatry Report
Issue Links: Editorial Information | PDF of Issue

CHPR_QA2_Self Harm_KDG photo.jpgKatherine L. Dixon-Gordon, PhD. 

Associate professor; Director of Clinical Training and Clinical Program Head, Psychological and Brain Sciences, University of Massachusetts, Amherst, MA.

Dr. Dixon-Gordon has no financial relationships with companies related to this material.

Dr. Dixon-Gordon sheds light on the motivations for nonsuicidal self-injury (NSSI) and provides strategies for patient treatment.


Read More
Expert Q&A

Understanding Suicide: Prevention and Intervention Strategies

April 1, 2024
J. John Mann, MD
From The Carlat Hospital Psychiatry Report
Issue Links: Editorial Information | PDF of Issue

CHPR_QA1_Suicide Prvtn_JJohnMann_photo.pngJ. John Mann, MD.

Paul Janssen Professor of Translational Neuroscience in Psychiatry and Radiology; Director, Molecular Imaging and Neuropathology Division; Co-Director, Columbia Center for Prevention and Treatment of Depression, Columbia University/New York State Psychiatric Institute, New York, NY.

Dr. Mann receives royalties from the Research Foundation for Mental Hygiene for the commercial use of the Columbia-Suicide Severity Rating Scale and royalties from Columbia University for the Columbia Psychiatry Pathways app. Relevant financial relationships listed for the author have been mitigated.

We examine effective suicide prevention techniques, highlighting simple yet impactful methods such as post-hospitalization follow-ups via phone calls or postcards. Dr. Mann offers insight into these and other interventions that have been successful in lowering suicide rates.


Read More
Clinical Update

Listen to Your Levels: Effective and Safe Prescribing of Lithium

April 1, 2024
Brian Holoyda, MD, MPH, MBA
From The Carlat Hospital Psychiatry Report
Issue Links: Editorial Information | PDF of Issue

Brian Holoyda, MD, MPH, MBA. Chief Psychiatrist, Contra Costa County Detention Health Services, Martinez, CA.

Dr. Holoyda has no financial relationships with companies related to this material. 

Here we focus on the safe administration of lithium, discussing how to manage both common and lesser- known side effects so that you can ensure a comprehensive approach to your patients’ care.


Read More
shutterstock_2163812691_GoodIdeas-Shutterstock.png
Clinical Update

Wernicke’s Encephalopathy and Korsakoff’s Syndrome

February 1, 2024
David C. Fipps, DO and Shirshendu Sinha, MBBS, MD
From The Carlat Hospital Psychiatry Report
Issue Links: Editorial Information | PDF of Issue

David C. Fipps, DO. Department of Psychiatry and Psychology, Mayo Clinic, Rochester, MN. Shirshendu Sinha, MBBS, MD. Department of Psychiatry and Psychology, Mayo Clinic, Scottsdale, AZ.

Dr. Fipps and Dr. Sinha have no financial relationships with companies related to this material.

Wernicke’s encephalopathy arises from thiamine (vitamin B1) deficiency and can evolve into Korsakoff's syndrome, marked by memory deficits and confabulation. Timely detection is key to halting the progression of symptoms. Here: A guide to what signs to watch for and how to treat this disorder.


Read More
Research Update

Initiation of Gender-Affirming Hormones and Mental Health Outcomes

January 31, 2024
Erin Conklin, MSN, CNP, PMHNP-BC
From The Carlat Hospital Psychiatry Report
Issue Links: Editorial Information | PDF of Issue

Erin Conklin, MSN, CNP, PMHNP-BC. Ms. Conklin has no financial relationships with companies related to this material.

A study on gender-affirming hormones in adolescents and adults found they are linked to better mental health in transgender people, leading to reduced psychological distress and suicidal thoughts. The findings reinforce the Endocrine Society's advice to provide transgender adolescents with access to GAH.


Read More

CME Post-Test, Substance Use Disorders, CHPR, January/February/March 2024

January 31, 2024
From The Carlat Hospital Psychiatry Report
Issue Links: Editorial Information | PDF of Issue

By successfully completing the test you will be awarded a certificate for 2 CME credit.


Read More
Research Update

Are Individuals With Major Depressive Symptoms More Likely to Own a Gun in the United States?

January 31, 2024
Susan Siegfreid, MD.
From The Carlat Hospital Psychiatry Report
Issue Links: Editorial Information | PDF of Issue

Susan L. Siegfreid, MD. Dr. Siegfreid has no financial relationships with companies related to this material.

A survey of gun ownership and gun purchasing plans found that individuals with depressive symptoms were significantly more likely to purchase a gun, or plan to purchase a gun, compared to non-depressed individuals, especially during the COVID-19 pandemic.


Read More
Research Update

Sublingual Dexmedetomidine for Acute Agitation in Bipolar Disorder

January 31, 2024
Sébastien Hardy, PharmD, BCPS.
From The Carlat Hospital Psychiatry Report
Issue Links: Editorial Information | PDF of Issue

Sébastien Hardy, PharmD, BCPS. Dr. Hardy has no financial relationships with companies related to this material.

Sublingual dexmedetomidine was found to work effectively and quickly for mild to moderate agitation in patients with bipolar disorder.


Read More
Clinical Update

Inpatient Use of Benzodiazepines for Patients With Substance Use Disorders

January 31, 2024
Audrey Abelleira, PharmD, BCPP
From The Carlat Hospital Psychiatry Report
Issue Links: Editorial Information | PDF of Issue

Audrey Abelleira, PharmD, BCPP. Clinical pharmacist practitioner, VA Connecticut Healthcare System; clinical instructor, Yale School of Medicine, New Haven, CT.

Dr. Abelleira has no financial relationships with companies related to this material.

Benzodiazepines are highly beneficial for managing anxiety and agitation in psychiatric inpatient settings, but we must be cautious about prescribing them to patients with substance use disorders (SUDs). Here we review strategies to reduce the risk of benzodiazepine misuse and discuss alternative medication options, including second-generation antipsychotics, antidepressants, gabapentin, and pregabalin.


Read More
Previous 1 2 3 4 5 6 7 8 9 … 14 15 Next
Carlat Total Access Subscriptions: Get access to every article on the website.

Complete access to every article you search on the website.

Shop for Total Access
Free Psychiatry Updates
The latest unbiased psychiatric information sent to your inbox.
Specify Your Interests
Featured Book
  • MFB7e_Print_App_Access.png

    Medication Fact Book for Psychiatric Practice, Seventh Edition (2024) - Regular Bound Book

    The updated 2024 reference guide covering the most commonly prescribed medications in psychiatry.
    READ MORE
Featured Video
  • KarXT (Cobenfy)_ The Breakthrough Antipsychotic That Could Change Everything.jpg
    General Psychiatry

    KarXT (Cobenfy): The Breakthrough Antipsychotic That Could Change Everything

    Read More
Featured Podcast
  • shutterstock_2637648401.jpg
    General Psychiatry

    Psychopharm Secrets: Coming Off Meds

    There’s a hidden placebo response to watch for when patients stop meds on their own.
    Listen now
Recommended
  • Join Our Writing Team

    July 18, 2024
    WriteForUs.png
  • Insights About a Rare Transmissible Form of Alzheimer's Disease

    February 9, 2024
    shutterstock_2417738561_PeopleImages.com_Yuri A.png
  • How to Fulfill the DEA's One Time, 8-Hour Training Requirement for Registered Practitioners

    May 24, 2024
    DEA_Checkbox.png
  • Join Our Writing Team

    July 18, 2024
    WriteForUs.png
  • Insights About a Rare Transmissible Form of Alzheimer's Disease

    February 9, 2024
    shutterstock_2417738561_PeopleImages.com_Yuri A.png
  • How to Fulfill the DEA's One Time, 8-Hour Training Requirement for Registered Practitioners

    May 24, 2024
    DEA_Checkbox.png
  • Join Our Writing Team

    July 18, 2024
    WriteForUs.png
  • Insights About a Rare Transmissible Form of Alzheimer's Disease

    February 9, 2024
    shutterstock_2417738561_PeopleImages.com_Yuri A.png
  • How to Fulfill the DEA's One Time, 8-Hour Training Requirement for Registered Practitioners

    May 24, 2024
    DEA_Checkbox.png

About

  • About Us
  • CME Center
  • FAQ
  • Contact Us

Shop Online

  • Newsletters
  • Multimedia Subscriptions
  • Books
  • eBooks
  • ABPN Self-Assessment Courses

Newsletters

  • The Carlat Psychiatry Report
  • The Carlat Child Psychiatry Report
  • The Carlat Addiction Treatment Report
  • The Carlat Hospital Psychiatry Report
  • The Carlat Geriatric Psychiatry Report
  • The Carlat Psychotherapy Report

Contact

carlat@thecarlatreport.com

866-348-9279

PO Box 626, Newburyport MA 01950

Follow Us

Please see our Terms and Conditions, Privacy Policy, Subscription Agreement, Use of Cookies, and Hardware/Software Requirements to view our website.

© 2025 Carlat Publishing, LLC and Affiliates, All Rights Reserved.